• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NMS
    99.41 2.96(3.07%) Dec 18, 4:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (89,225) (106,014) (57,649)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation10,229  9,035  5,125  
    Adjustments To Net Income18,457  (9,665)21,384  
    Changes In Accounts Receivables(4,144)1,364  1,982  
    Changes In Liabilities(2,822)(13,889)(71,310)
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(1,152)3,560  13,400  
    Total Cash Flow From Operating Activities (68,657) (115,609) (87,068)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(4,006)(8,348)(1,291)
    Investments(126,499)11,884  83,250  
    Other Cash flows from Investing Activities -  (162) -  
    Total Cash Flows From Investing Activities (130,505) 3,374   81,959  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock202,315  93,771  738  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities(1,389)(359) -  
    Total Cash Flows From Financing Activities 200,926   93,412   738  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 1,764   (18,823) (4,371)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.